Integrative framework for identification of key cell identity genes uncovers determinants of ES cell identity and homeostasis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 16, 2014, Pages

  Cinghu, Senthilkumar ^a   Yellaboina, Sailu ^a,b   Freudenberg, Johannes M ^a   Ghosh, Swati ^a   Zheng, Xiaofeng ^a   Oldfield, Andrew J ^a   Lackford, Brad L ^a   Zaykin, Dmitri V ^a   Hu, Guang ^a   Jothi, Raja ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF HYDERABAD   (India)

Author keywords

Computational biology; Pluripotency; RNA binding protein; ROS; Transcription

Indexed keywords

NUCLEOLIN; PROTEIN P53;

ARTICLE; CANCER CELL; CANCER STEM CELL; CELL DIFFERENTIATION; CELL FATE; CELL RENEWAL; CONTROLLED STUDY; EMBRYONIC STEM CELL; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ASSOCIATION; HOMEOSTASIS; HUMAN; HUMAN CELL; LOSS OF FUNCTION MUTATION; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RNA INTERFERENCE;

COMPUTATIONAL BIOLOGY; PLURIPOTENCY; RNA-BINDING PROTEIN; ROS; TRANSCRIPTION;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION; HOMEODOMAIN PROTEINS; HOMEOSTASIS; MICE; OXIDATIVE STRESS; PHOSPHOPROTEINS; PLURIPOTENT STEM CELLS; REACTIVE OXYGEN SPECIES; REPRODUCIBILITY OF RESULTS; RNA INTERFERENCE; RNA-BINDING PROTEINS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84899082334     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1318598111     Document Type: Article

References (64)

1. Mohr S, Bakal C, Perrimon N (2010) Genomic screening with RNAi: Results and challenges. Annu Rev Biochem 79:37-64.
2. Boutros M, Ahringer J (2008) The art and design of genetic screens: RNA interference. Nat Rev Genet 9(7):554-566. (Pubitemid 351861541)
3. Zender L, et al. (2008) An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer. Cell 135(5):852-864.
4. Luo J, et al. (2009) A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. Cell 137(5):835-848.
5. Zuber J, et al. (2011) RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature 478(7370):524-528.
6. Ivanova N, et al. (2006) Dissecting self-renewal in stem cells with RNA interference. Nature 442(7102):533-538. (Pubitemid 44167907)
7. Fazzio TG, Huff JT, Panning B (2008) An RNAi screen of chromatin proteins identifies Tip60-p400 as a regulator of embryonic stem cell identity. Cell 134(1):162-174. (Pubitemid 351905738)
8. Hu G, et al. (2009) A genome-wide RNAi screen identifies a new transcriptional module required for self-renewal. Genes Dev 23(7):837-848.
9. Ding L, et al. (2009) A genome-scale RNAi screen for Oct4 modulators defines a role of the Paf1 complex for embryonic stem cell identity. Cell Stem Cell 4(5):403-415.
10. Chia NY, et al. (2010) A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity. Nature 468(7321):316-320.
11. Wuestefeld T, et al. (2013) A Direct in vivo RNAi screen identifies MKK4 as a key regulator of liver regeneration. Cell 153(2):389-401.
12. Krishnan MN, et al. (2008) RNA interference screen for human genes associated with West Nile virus infection. Nature 455(7210):242-245.
13. Baril M, et al. (2013) Genome-wide RNAi screen reveals a new role of a WNT/CTNNB1 signaling pathway as negative regulator of virus-induced innate immune responses. PLoS Pathog 9(6):e1003416.
14. Subramanian V, Klattenhoff CA, Boyer LA (2009) Screening for novel regulators of embryonic stem cell identity. Cell Stem Cell 4(5):377-378.
15. Wu SM, Hochedlinger K (2011) Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat Cell Biol 13(5):497-505.
16. Robinton DA, Daley GQ (2012) The promise of induced pluripotent stem cells in research and therapy. Nature 481(7381):295-305.
17. Suvà ML, Riggi N, Bernstein BE (2013) Epigenetic reprogramming in cancer. Science 339(6127):1567-1570.
18. Chen X, et al. (2008) Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133(6):1106-1117. (Pubitemid 351787745)
19. Young RA (2011) Control of the embryonic stem cell state. Cell 144(6):940-954.
20. Jaenisch R, Young R (2008) Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132(4):567-582. (Pubitemid 351253686)
21. Ng HH, Surani MA (2011) The transcriptional and signalling networks of pluripotency. Nat Cell Biol 13(5):490-496.
22. Orkin SH, Hochedlinger K (2011) Chromatin connections to pluripotency and cellular reprogramming. Cell 145(6):835-850.
23. Ho L, et al. (2011) esBAF facilitates pluripotency by conditioning the genome for LIF/STAT3 signalling and by regulating polycomb function. Nat Cell Biol 13(8):903-913.
24. Freudenberg JM, et al. (2012) Acute depletion of Tet1-dependent 5-hydroxymethylcytosine levels impairs LIF/Stat3 signaling and results in loss of embryonic stem cell identity. Nucleic Acids Res 40(8):3364-3377.
25. Melton C, Judson RL, Blelloch R (2010) Opposing microRNA families regulate self-renewal in mouse embryonic stem cells. Nature 463(7281):621-626.
26. Marson A, et al. (2008) Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 134(3):521-533.
27. Wang Y, et al. (2008) Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation. Nat Genet 40(12):1478-1483.
28. Zalzman M, et al. (2010) Zscan4 regulates telomere elongation and genomic stability in ES cells. Nature 464(7290):858-863.
29. Bilodeau S, Kagey MH, Frampton GM, Rahl PB, Young RA (2009) SetDB1 contributes to repression of genes encoding developmental regulators and maintenance of ES cell state. Genes Dev 23(21):2484-2489.
30. Breitling R, Armengaud P, Amtmann A, Herzyk P (2004) Rank products: A simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett 573(1-3):83-92. (Pubitemid 39141040)
31. Pijnappel WW, et al. (2013) A central role for TFIID in the pluripotent transcription circuitry. Nature 495(7442):516-519.
32. Buckley SM, et al. (2012) Regulation of pluripotency and cellular reprogramming by the ubiquitin-proteasome system. Cell Stem Cell 11(6):783-798.
33. Kagey MH, et al. (2010) Mediator and cohesin connect gene expression and chromatin architecture. Nature 467(7314):430-435.
34. Ho L, et al. (2009) An embryonic stem cell chromatin remodeling complex, esBAF, is essential for embryonic stem cell self-renewal and pluripotency. Proc Natl Acad Sci USA 106(13):5181-5186.
35. Ho L, et al. (2009) An embryonic stem cell chromatin remodeling complex, esBAF, is an essential component of the core pluripotency transcriptional network. Proc Natl Acad Sci USA 106(13):5187-5191.
36. Jia J, et al. (2012) Regulation of pluripotency and self- renewal of ESCs through epigenetic-threshold modulation and mRNA pruning. Cell 151(3):576-589.
37. Takahashi K, Mitsui K, Yamanaka S (2003) Role of ERas in promoting tumour-like properties in mouse embryonic stem cells. Nature 423(6939):541-545. (Pubitemid 36648578)
38. Mongelard F, Bouvet P (2007) Nucleolin: A multiFACeTed protein. Trends Cell Biol 17(2):80-86. (Pubitemid 46199181)
39. Abdelmohsen K, Gorospe M (2012) RNA-binding protein nucleolin in disease. RNA Biol 9(6):799-808.
40. Lin T, et al. (2005) p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol 7(2):165-171. (Pubitemid 40268131)
41. Silva J, Smith A (2008) Capturing pluripotency. Cell 132(4):532 -536.
42. Yang A, et al. (2011) Nucleolin maintains embryonic stem cell self-renewal by suppression of p53 protein-dependent pathway. J Biol Chem 286(50):43370-43382.
43. Miniard AC, Middleton LM, Budiman ME, Gerber CA, Driscoll DM (2010) Nucleolin binds to a subset of selenoprotein mRNAs and regulates their expression. Nucleic Acids Res 38(14):4807-4820.
44. Takagi M, Absalon MJ, McLure KG, Kastan MB (2005) Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin. Cell 123(1):49-63. (Pubitemid 41414528)
45. Jain AK, et al. (2012) p53 regulates cell cycle and microRNAs to promote differentiation of human embryonic stem cells. PLoS Biol 10(2):e1001268.
46. Krizhanovsky V, Lowe SW (2009) Stem cells: The promises and perils of p53. Nature 460(7259):1085-1086.
47. Li M, et al. (2012) Distinct regulatory mechanisms and functions for p53-activated and p53-repressed DNA damage response genes in embryonic stem cells. Mol Cell 46(1):30-42.
48. Liu B, Chen Y, St Clair DK (2008) ROS and p53: A versatile partnership. Free Radic Biol Med 44(8):1529-1535.
49. Ying QL, et al. (2008) The ground state of embryonic stem cell self-renewal. Nature 453(7194):519-523.
50. Esteban MA, et al. (2010) Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 6(1):71-79.
51. Griffith OW (1982) Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis. J Biol Chem 257(22):13704-13712.
52. Stead E, et al. (2002) Pluripotent cell division cycles are driven by ectopic Cdk2, cyclin A/E and E2F activities. Oncogene 21(54):8320-8333. (Pubitemid 35477872)
53. Zhao T, Xu Y (2010) p53 and stem cells: New developments and new concerns. Trends Cell Biol 20(3):170-175.
54. Aladjem MI, et al. (1998) ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage. Curr Biol 8(3):145-155. (Pubitemid 28091572)
55. Lee DF, et al. (2012) Regulation of embryonic and induced pluripotency by aurora kinase-p53 signaling. Cell Stem Cell 11(2):179-194.
56. Han MK, et al. (2008) SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization. Cell Stem Cell 2(3):241-251.
57. Sablina AA, et al. (2005) The antioxidant function of the p53 tumor suppressor. Nat Med 11(12):1306-1313. (Pubitemid 41752911)
58. Ben-Porath I, et al. (2008) An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40(5):499-507. (Pubitemid 351601215)
59. Zbinden M, et al. (2010) NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53. EMBO J 29(15):2659-2674.
60. Diehn M, et al. (2009) Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458(7239):780-783.
61. Palmer NP, Schmid PR, Berger B, Kohane IS (2012) A gene expression profile of stem cell pluripotentiality and differentiation is conserved across diverse solid and hematopoietic cancers. Genome Biol 13(8):R71.
62. Hong F, et al. (2006) RankProd: A bioconductor package for detecting differentially expressed genes in meta-analysis. Bioinformatics 22(22):2825-2827. (Pubitemid 44742407)
63. Zaykin DV (2011) Optimally weighted Z-test is a powerful method for combining probabilities in meta-analysis. J Evol Biol 24(8):1836-1841.
64. Keene JD, Komisarow JM, Friedersdorf MB (2006) RIP-Chip: The isolation and identification of mRNAs, microRNAs and protein components of ribonucleoprotein complexes from cell extracts. Nat Protoc 1(1):302-307.